Target intelligence / Profile preview

Cyclin-dependent kinase 4 messenger RNA 3' untranslated region (CDK4 mRNA 3'-UTR)

Target
CDK4 mRNA 3'-UTR
Molecular classification
Messenger RNA, Untranslated region, Regulatory RNA element
01

Overview

The Cyclin-dependent kinase 4 (CDK4) messenger RNA 3' untranslated region (3'-UTR) is a vital regulatory sequence located immediately downstream of the protein-coding region. It serves as a primary site for post-transcriptional regulation, containing multiple binding motifs for microRNAs (miRNAs) such as miR-124, miR-34a, and miR-200c, which negatively regulate CDK4 expression (PubMed: 24607534, 18364343). Because CDK4 is a central mediator of the G1/S phase transition in the cell cycle, its overexpression is a common driver in various cancers. This overexpression is often facilitated by the loss of miRNA-mediated control at the 3'-UTR or specific genetic variations within the region. Therapeutic approaches targeting this region involve the use of miRNA mimics or antisense oligonucleotides (ASOs) to suppress CDK4 protein production at the source. This target is particularly significant in precision oncology, where polymorphisms in the 3'-UTR, such as rs14734, can serve as biomarkers for disease susceptibility or treatment response (PubMed: 25663388). Unlike traditional small-molecule inhibitors that target the CDK4 protein, targeting the 3'-UTR aims to reduce the total abundance of the oncogenic protein through mRNA degradation or translational blockade.

Other names
CDK4 3'-UTRCyclin-dependent kinase 4 3'-untranslated regionCDK4 mRNA regulatory regionCDK4 3'UTR
02

Mechanism of action

Post-transcriptional gene silencing via microRNA-mediated mRNA degradation or translational inhibition.

03

Biological functions

Regulation of mRNA stabilityPost-transcriptional regulationCell cycle controlMicroRNA binding siteTranslational control
04

Disease associations

CancerMelanomaGlioblastomaBreast cancerOsteosarcomaNasopharyngeal carcinoma
05

Safety considerations

Off-target effects of RNA-based therapeuticsDelivery efficiency to target tissuesPotential for compensatory activation of CDK6Immune activation by exogenous RNA
06

Interacting drugs

miR-124 mimics

3 more in the full profile.

07

Biomarkers

CDK4 mRNA expression levelsmiR-124 expression levelsrs14734 single nucleotide polymorphismmiR-34a expression levels

Beyond the preview

Go deeper on Cyclin-dependent kinase 4 messenger RNA 3' untranslated region (CDK4 mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin-dependent kinase 4 messenger RNA 3' untranslated region (CDK4 mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call